Home/Filings/4/0000899243-22-036299
4//SEC Filing

MOSCICKI RICHARD A 4

Accession 0000899243-22-036299

CIK 0001664106other

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 9:09 PM ET

Size

8.4 KB

Accession

0000899243-22-036299

Insider Transaction Report

Form 4
Period: 2022-11-16
Transactions
  • Disposition to Issuer

    Common Stock

    2022-11-163,9160 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2022-11-1612,5000 total
    Exercise: $0.38Exp: 2032-06-17Common Stock (12,500 underlying)
Footnotes (3)
  • [F1]Pursuant to the Agreement and Plan of Merger, dated as of October 3, 2022 (the "Merger Agreement"), by and among LogicBio Therapeutics, Inc. (the "Company"), Alexion Pharmaceuticals, Inc. ("Parent") and Camelot Merger Sub, Inc. ("Merger Sub"), on November 16, 2022 (the "Effective Time"), Merger Sub merged with and into the Company (the "Merger"), with the Company continuing as the surviving corporation in the Merger and as a wholly-owned subsidiary of Parent, and, at the Effective Time, each share of common stock, par value $0.0001 per share, of the Company was cancelled and converted into the right to receive $2.07 in cash, without interest, less any applicable withholding taxes.
  • [F2]The options were granted on June 17, 2022. The options were scheduled to vest in full on the earlier of (i) the first anniversary of the grant date, and (ii) the day prior to the Company's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service with the Company on the vesting date.
  • [F3]At the Effective Time, each option was cancelled pursuant to the terms of the Merger Agreement; provided, that each option with a per share exercise price equal to or greater than $2.07 was automatically cancelled for no consideration. For more information see the Solicitation/Recommendation Statement on Schedule 14D-9 filed by the Company with the United States Securities and Exchange Commission on October 18, 2022.

Issuer

LogicBio Therapeutics, Inc.

CIK 0001664106

Entity typeother
IncorporatedMA

Related Parties

1
  • filerCIK 0001021029

Filing Metadata

Form type
4
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 9:09 PM ET
Size
8.4 KB